Even more concerning was that rosuvastatin users had higher risks than those taking atorvastatin. There was an 8% higher risk of blood in the urine, a 17% higher risk of protein in the urine, and a 15 ...
The metabolic syndrome is increasingly found in a substantial and rising proportion of the US population and is associated with increased risk of cardiovascular disease events (acute coronary ...
Few real-world studies have investigated the risks of hematuria and proteinuria associated with rosuvastatin use. Rosuvastatin may increase the risk of hematuria, proteinuria, and kidney failure, ...
Use of OTC dietary supplements is increasingly common, sometimes replacing guideline-recommended therapies. Rosuvastatin was associated with larger reductions in LDL-C compared with placebo, fish oil, ...
For the heterozygous type, rosuvastatin can be used in children who are at least 8 years old. For the homozygous type, rosuvastatin can be used in children as terramycin 250 mg as 7 years old. Crestor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results